We have recently shown that loss of TβRII expression correlated significantly with better prognosis in estrogen receptor negative breast cancer patients [12], but little is known about the influence of the various downstream TGF-β signal transduction pathways on breast cancer prognosis. Here, TGFBR2 is linked to breast carcinoma.